These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 11120054)
21. CD25+ regulatory cells generated by intratracheal delivery of alloantigen. Akiyama Y; Shibutani S; Matsumoto K; Kitajima M; Aramaki O; Yokoyama T; Kan S; Ikeda Y; Shirasugi N; Niimi M Transplant Proc; 2002 Aug; 34(5):1443-4. PubMed ID: 12176431 [No Abstract] [Full Text] [Related]
22. Study of donor-specific antigens in inducing tolerance and enhancing graft survival. Lu YP; Wang J; Yang YR; Tang XD Transplant Proc; 1999; 31(1-2):846. PubMed ID: 10083369 [No Abstract] [Full Text] [Related]
23. Induction of transplantation tolerance using a nondepleting anti-CD4 MAb and donor-specific transfusion before transplantation: evidence that a critical period of time is required for the development of immunological unresponsiveness. Saitovitch D; Bushell AR; Morris PJ; Wood KJ Transplant Proc; 1995 Feb; 27(1):117-8. PubMed ID: 7878834 [No Abstract] [Full Text] [Related]
24. CD4-targeted therapy induces "infectious" tolerance to cardiac allografts in sensitized rat recipients. Onodera K; Lehmann M; Volk HD; Sayegh MH; Kupiec-Weglinski JW Transplant Proc; 1997 May; 29(3):1907-8. PubMed ID: 9142316 [No Abstract] [Full Text] [Related]
25. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive. Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556 [TBL] [Abstract][Full Text] [Related]
26. Helper T lymphocyte unresponsiveness to cardiac allografts following transient depletion of CD4-positive cells. Implications for cellular and humoral responses. Bishop DK; Li W; Chan SY; Ensley RD; Shelby J; Eichwald EJ Transplantation; 1994 Sep; 58(5):576-84. PubMed ID: 7522364 [TBL] [Abstract][Full Text] [Related]
27. Evidence that long-term cardiac allograft survival induced by anti-CD4 monoclonal antibody does not require depletion of CD4+ T cells. Darby CR; Morris PJ; Wood KJ Transplantation; 1992 Sep; 54(3):483-90. PubMed ID: 1384184 [TBL] [Abstract][Full Text] [Related]
28. Tolerance to heart and kidney grafts induced by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) versus depleting anti-CD4 monoclonal antibody (OX-38) with donor antigen administration. Motoyama K; Arima T; Lehmann M; Flye MW Surgery; 1997 Aug; 122(2):213-9; discussion 219-20. PubMed ID: 9288125 [TBL] [Abstract][Full Text] [Related]
29. Administration of anti-CD4 monoclonal antibody with intrathymic injection of alloantigen results in rat cardiac allograft tolerance. Arima T; Goss JA; Walp LA; Flye MW Surgery; 1995 Aug; 118(2):265-72; discussion 272-3. PubMed ID: 7638743 [TBL] [Abstract][Full Text] [Related]
30. Indefinite survival of fully allogeneic cardiac grafts induced by antigen delivery through the alimentary tract. Niimi M; Ikeda Y; Kan S; Shirasugi N; Hamano K J Thorac Cardiovasc Surg; 2001 Sep; 122(3):629-30. PubMed ID: 11547327 [No Abstract] [Full Text] [Related]
32. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. Hara M; Kingsley CI; Niimi M; Read S; Turvey SE; Bushell AR; Morris PJ; Powrie F; Wood KJ J Immunol; 2001 Mar; 166(6):3789-96. PubMed ID: 11238621 [TBL] [Abstract][Full Text] [Related]
33. FK 506 versus cyclosporine in combination with anti-CD4/CD8 monoclonal antibodies. Moffatt SD; Metcalfe SM Transplant Proc; 1999 Nov; 31(7):2740. PubMed ID: 10578271 [No Abstract] [Full Text] [Related]
34. Transgenic anti-CD4 monoclonal antibody secretion by mouse segmental pancreas allografts promotes long term survival. Mottram PL; Murray-Segal LJ; Han W; Zhan Y; Brady JL; Lew AM Transpl Immunol; 2000 Nov; 8(3):203-9. PubMed ID: 11147701 [TBL] [Abstract][Full Text] [Related]
35. Analysis of donor-specific unresponsiveness to rat allografts by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus donor antigen. Motoyama K; Lehmann M; Flye MW Transplant Proc; 1999; 31(1-2):1237-8. PubMed ID: 10083552 [No Abstract] [Full Text] [Related]
36. Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Wong W; Morris PJ; Wood KJ Transplantation; 1997 May; 63(10):1490-4. PubMed ID: 9175815 [TBL] [Abstract][Full Text] [Related]
37. The generation of CD25+ CD4+ regulatory T cells that prevent allograft rejection does not compromise immunity to a viral pathogen. Bushell A; Jones E; Gallimore A; Wood K J Immunol; 2005 Mar; 174(6):3290-7. PubMed ID: 15749860 [TBL] [Abstract][Full Text] [Related]
38. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression. Saitovitch D; Morris PJ; Wood KJ Transplant Proc; 1995 Feb; 27(1):119-20. PubMed ID: 7878844 [No Abstract] [Full Text] [Related]
39. Induction of donor-specific unresponsiveness to cardiac allografts in rats by pretransplant anti-CD4 monoclonal antibody therapy. Shizuru JA; Seydel KB; Flavin TF; Wu AP; Kong CC; Hoyt EG; Fujimoto N; Billingham ME; Starnes VA; Fathman CG Transplantation; 1990 Sep; 50(3):366-73. PubMed ID: 1976282 [TBL] [Abstract][Full Text] [Related]
40. Importance of thymus to maintain operational tolerance to fully allogeneic cardiac grafts. Niimi M; Shirasugi N; Ikeda Y; Kan S; Takami H; Hamano K Ann Thorac Surg; 2001 Sep; 72(3):735-9. PubMed ID: 11565650 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]